ETF Managers Group, LLC Intra Cellular Therapies, Inc. Transaction History

ETF Managers Group, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$7.47 - $14.03 $162,196 - $304,633	-21,713 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$10.65 - $14.29 $43,707 - $58,646	-4,104 Reduced 15.9%	21,713 $276,000
Q1 2019 May 07, 2019	SELL	$10.9 - $14.09 $24,852 - $32,125	-2,280 Reduced 8.11%	25,817 $314,000
Q4 2018 Feb 01, 2019	SELL	$10.36 - $20.96 $41,336 - $83,630	-3,990 Reduced 12.43%	28,097 $320,000
Q3 2018 Nov 14, 2018	BUY	$17.77 - $22.9 $145,856 - $187,963	8,208 Added 34.37%	32,087 $696,000
Q2 2018 Aug 14, 2018	BUY	$17.33 - $23.4 $1,975 - $2,667	114 Added 0.48%	23,879 $2.13 Million
Q1 2018 May 15, 2018	BUY	$15.16 - $25.49 $360,277 - $605,769	23,765 New	23,765 $460,000

378

84.1M

319K

143K

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $7.86B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

Get notified when there are updates to the investment portfolio of ETF Managers Group, LLC, based on Form 13F filings with the SEC.

Stay updated on ETF Managers Group, LLC with notifications on news.